Experimental treatments that use the body's own immune system to fight cancer are nothing short of amazing. At the year's biggest scientific conference for cancer drug developers, bluebird bio (NASDAQ: BLUE)showed us that its candidate can prolong the lives of people who had exhausted all available options.
3 Reasons Amazing Isn't Good Enough for This Biotech Stock
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться